DCOY insider transactions
Decoy Therapeutics Inc. (DCOY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
DCOY insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Decoy Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Jonathan I LieberDirector+$7,016
- Frederick Pierce IIChief Executive Officer
- Peter Klaus MarschelChief Business Officer
- Mark J RosenblumChief Financial Officer+$50.9K
- Barbara Louise HibnerChief Scientific Officer
- Arnold C HanishDirector+$28.6K-$17.27
- Paul LammersDirector
- Tess BurlesonDirector+$4,986
- William K. McVicarDirector+$5,000
- Patricia G. GauthierDirector, since July 2026
- David J. ArthurChief Executive Officer, Director+$62.5K
- Bruce J McCreedy Jr.Director
Recent Form 3, 4, and 5 filings for DCOY
- Director Lieber Jonathan I was granted 2,000 shares, increasing direct ownership by 100,000% to 2,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Business Officer Marschel Peter Klaus was granted 3,900 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Executive Officer Pierce Frederick Ii was granted 33,455 shares, increasing direct ownership by 2,409% to 34,844 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Financial Officer Rosenblum Mark J was granted 9,682 shares, increasing direct ownership by 576% to 11,363 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Scientific Officer Hibner Barbara Louise was granted 4,216 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Hanish Arnold C was granted 3,000 shares, increasing direct ownership by 718% to 3,418 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Lammers Paul was granted 2,000 shares, increasing direct ownership by 200,000% to 2,001 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Burleson Tess was granted 2,000 shares, increasing direct ownership by 100,000% to 2,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Mcvicar William K. was granted 3,000 shares, increasing direct ownership by 150,000% to 3,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Gauthier Patricia G. was granted 2,000 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- SEC Form 3 filed by new insider Gauthier Patricia G.3 - Decoy Therapeutics Inc. (0001615219) (Issuer)